We are live on ! Find out more
OKYO

OKYO Pharma
OKYO

7 hedge funds and large institutions have $1.18M invested in OKYO Pharma in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding

Funds holding: 6 → 7 (+1)

16% more capital invested

Capital invested by funds: $1.02M → $1.18M (+$158K)

0.07% more ownership

Funds ownership: 2.95% → 3.03% (+0.07%)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$17.7K
2
Citadel Advisors
Citadel Advisors
Florida
+$6.28K
3
UBS Group
UBS Group
Switzerland
+$2.65K

Top Sellers

No sellers this quarter

OKYO Hedge Fund Activity: Q4 2024 in Review

7 of the 7,611 institutional investors tracked by Wall St. Rank reported a position in OKYO Pharma (OKYO) for Q4 2024, worth a combined $1.18M — up 16% from $1.02M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new OKYO positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $17.7K.

  • 7 institutional investors held OKYO Pharma (OKYO) as of Q4 2024, up from 6 in Q3 2024.
  • Funds reported $1.18M of OKYO Pharma stock for Q4 2024, up 16% quarter-over-quarter.
  • 1 fund opened new OKYO Pharma positions in Q4 2024 and 0 closed out, a net change of +1 holder.
  • The largest OKYO Pharma buyer in Q4 2024 was Renaissance Technologies, an estimated $17.7K added.

Based on aggregated 13F filings for Q4 2024.